Company
Sapporo Clinical Laboratory, Inc.
Headquarters: Sapporo, Japan
Employees: 819
CEO: Mitsuru Oketani
Market Cap
¥3.34 Billion
JPY as of Jan. 1, 2024
US$23.7 Million
Sapporo Clinical Laboratory, Inc. Categories
Japan Healthcare Pharmaceutical RetailersJapan Healthcare Japan Pharmaceutical Retailers
Top Competitors by Market Capitalization
Industry: Pharmaceutical Retailers
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Sapporo Clinical Laboratory Inc. operates dispensing pharmacies in Japan. The company offers laboratory testing, pathological examination, and holter inspection services. It also provides food hygiene environmental inspection, including food/processed product, facility hygiene, and food handler inspection services; and radiation management services. In addition, the company develops, sells, and maintains software, such as SCAN clinical testing systems; and offers support services for opening new clinics. Further, it provides HiWeb21 inspection result inquiry services. Sapporo Clinical Laboratory Inc. was founded in 1965 and is headquartered in Sapporo, Japan.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Sapporo Clinical Laboratory, Inc. has the following listings and related stock indices.
Stock: JPX: 9776 wb_incandescent